| Title : Patient and caregiver outcomes after 6 +\/- 1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease: the Belgian FExT study - Mets_2007_Curr.Med.Res.Opin_23_2485 |
| Author(s) : Mets T , Vandewoude M , Jacquy J , Deblander A , MacDonald K , Sloesen A , Abraham I |
| Ref : Curr Med Res Opin , 23 :2485 , 2007 |
| Abstract : Mets_2007_Curr.Med.Res.Opin_23_2485 |
| ESTHER : Mets_2007_Curr.Med.Res.Opin_23_2485 |
| PubMedSearch : Mets_2007_Curr.Med.Res.Opin_23_2485 |
| PubMedID: 17784995 |
Mets T, Vandewoude M, Jacquy J, Deblander A, MacDonald K, Sloesen A, Abraham I (2007)
Patient and caregiver outcomes after 6 +\/- 1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease: the Belgian FExT study
Curr Med Res Opin
23 :2485
Mets T, Vandewoude M, Jacquy J, Deblander A, MacDonald K, Sloesen A, Abraham I (2007)
Curr Med Res Opin
23 :2485